Delek Israel Properties: How Much Of The Upgrade Pipeline Can The Balance Sheet Really Fund
Delek Israel Properties enters 2026 with a relatively comfortable balance sheet, about ILS 228 million of liquid sources in S&P's 12-month view, ILS 1.43 billion of unencumbered real estate, and wide covenant headroom. But the remaining ILS 642 million investment envelope is far larger than what 2025 cash, FFO, or management AFFO can fund on their own, so the real test is pacing, project financing, and refinancing, not just optical balance-sheet strength.
The main article already argued that the key question at Delek Israel Properties has shifted from paper value to conversion: can the company turn a very large enhancement pipeline into actual NOI. This continuation isolates only the funding layer. Can the balance sheet at the end of 2025 and the start of 2026 carry a remaining investment envelope of ILS 642 million without rebuilding balance-sheet pressure.
The short answer is sharp. It can probably fund the next year. It cannot fund the whole pipeline from the cash box alone. On a 12-month read the company looks funded. Once the horizon moves from that window to the full ILS 642 million, the picture changes quickly. That number is about 2.8 times S&P's liquid-source stack, about 3.2 times the cash balance framed in the presentation, and more than 13 times management AFFO.
This is the right place to use an all-in cash-flexibility lens, not a normalized earning-power lens. The question is not whether the assets should eventually produce attractive NOI. The question is whether the balance sheet can finance the distance until then without leaning too heavily again on the capital markets, the banks, or asset recycling.
The 12-month test: funded, but only for the first leg
The clearest positive evidence comes from the January 18, 2026 rating report. S&P estimates that the ratio of sources to uses over the 12 months that began on October 1, 2025 should be above 1.2x. In more concrete terms, it points to about ILS 228 million of cash, short-term investments, and trading financial assets, against about ILS 17 million of short-term debt and current maturities and about ILS 100 million of enhancement capex. It also adds about ILS 15 million to ILS 20 million of annual operating cash flow and bank project financing.
That chart is intentionally conservative. It excludes the ILS 15 million to ILS 20 million of operating cash flow that S&P also assumes, and it gives no numeric value to project-specific bank financing. So even before those extra sources, the company still retains a meaningful cushion.
That is the real balance-sheet strength in this story. At December 31, 2025, equity reached ILS 1.109 billion, the equity-to-assets ratio stood at 51%, and net financial debt to adjusted NOI stood at 9.8 versus a ceiling of 17. In the March 2026 presentation the company also shows about ILS 1.43 billion of unencumbered real estate, roughly 73% of the asset base, and net LTV of 35.6%. This is not a stressed balance sheet. It is a balance sheet with room.
The January 11, 2026 refinancing also supports that read. The company repaid a CPI-linked ILS 200 million loan carrying 3.99% interest and replaced it with two fixed-rate, non-linked ILS 100 million loans carrying 5.15%. On a nominal basis that does not look cheaper. But the presentation itself frames a 1.75% to 2.0% potential interest saving, and the rating report says the recent refinancing was completed at a lower effective rate once indexation is included. In other words, the move does not only delay a maturity wall. It also reduces part of the CPI noise embedded in the financing line.
Where the problem really starts: moving from one year to the full ILS 642 million
The easy mistake is to take the 12-month cushion and project it over the entire enhancement pipeline. That is where the logic breaks. The remaining expected investment of ILS 642 million is split between ILS 252.4 million in assets already under construction or enhancement and ILS 389.8 million in assets still in planning. That means about 39% of the spend sits in the layer that is materially closer to delivery, while about 61% still depends on planning progress, permits, and timing.
That chart captures the core asymmetry. The expected NOI uplift is relatively balanced between the two layers, ILS 41.6 million from the assets already in execution and ILS 47.4 million from the planning layer. But the capital still required is weighted much more heavily toward the less mature side of the pipeline. So the real question is not the size of the opportunity. It is the pace at which the company can convert that opportunity into a funded path.
S&P itself signals exactly that. In its base case it does not assume immediate funding of the full ILS 642 million. It assumes total investments and acquisitions of about ILS 450 million to ILS 550 million over the next two years, and in its liquidity section it frames only about ILS 100 million of enhancement capex in the first 12 months. That is the difference between a balance sheet that can finance a bridge and one that can absorb the whole road at once.
Cash alone is not enough, and neither is AFFO
To see why, it helps to separate balance-sheet cushion from internal cash generation.
| Metric | Amount | The right read |
|---|---|---|
| Remaining investment envelope | ILS 642 million | The full enhancement pipeline that still needs capital |
| Liquid sources in the 12-month view | ILS 228 million | Enough for the first leg, not for the full envelope |
| Cash and cash equivalents in the presentation | ILS 200.7 million | A real cushion, but not full self-funding |
| 2025 operating cash flow | ILS 15.3 million | A recurring cash layer, but very small versus the pipeline |
| ISA-method FFO | ILS 12.0 million | The stricter read of recurring property earnings |
| Management AFFO | ILS 48.4 million | An earning-power metric, not a full funding bridge |
The most important line in that table is AFFO. Management presents ILS 48.4 million versus ILS 12.0 million of FFO under the Israel Securities Authority method. The ILS 36.4 million gap is driven mainly by four adjustments: ILS 15.6 million of debt-principal indexation, ILS 9.0 million of SG&A allocated to development, ILS 9.1 million of financing offset against the development component, and ILS 2.7 million of option-value adjustments. That is a legitimate metric if the goal is to measure the earning power of the stabilized income-producing platform. It is not a metric that proves the pipeline already finances itself.
The same caution applies to the company's representative NOI of about ILS 78 million. The directors' report states explicitly that this number already includes expected income from areas under enhancement that are supposed to begin contributing during 2026. So part of the comfort embedded in that headline already assumes early delivery. It is not all fully in-place rent today.
The 2025 cash build tells the same story. Operating cash flow was only ILS 15.3 million, while investing activity consumed ILS 109.2 million. Financing filled the gap, led by the July 2025 IPO that brought in ILS 169.2 million net. The directors' report is explicit that working capital improved mainly because of that equity raise. So the year-end cash pile is real, but it is not proof that the existing business already self-funds the enhancement program.
What really creates the breathing room
So what actually allows Delek Israel Properties to carry the pipeline without moving straight back into pressure. The answer is not ILS 15 million of operating cash flow. The answer is the combination of a conservative balance sheet, unencumbered assets, bank access, and capital-markets access.
The most important asset here is not cash. It is the stock of assets that can still support financing or refinancing. About ILS 1.43 billion of unencumbered real estate is a very large number relative to this company. Add roughly ILS 1.1 billion of equity, a roughly 45% to 51% equity-to-assets ratio depending on the measurement layer, and a stable rating, and the picture is clear: the company does not have free capital, but it does have room to keep drawing project finance, refinancing debt, and opening projects at a measured pace without immediately turning covenant headroom or liquidity into the main problem.
But 2026 itself is not a pure execution year. In its strategy section for the coming year the company says it intends not only to keep developing its existing assets, but also to look for additional income-producing assets, buy land, and examine larger stakes in associates or jointly held assets. That matters because not all of the current balance-sheet room is automatically reserved for the existing ILS 642 million pipeline. Some of that room could also be consumed by fresh capital allocation.
That is where the main open friction remains. The real risk is not the covenant. It is the pace. If investments are rolled out roughly along the path S&P assumes, if the assets closest to 2026 and 2027 delivery start converting into NOI, and if the company keeps opening project financing against its unencumbered asset base, the balance sheet should hold. If investment starts running materially ahead of deliveries, if the planning layer slips, or if the company adds new acquisitions in parallel, reliance on external funding comes back into the center of the story very quickly.
Bottom line
Today Delek Israel Properties has a balance sheet strong enough to finance the bridge into the first phase of pipeline maturity. It is not yet strong enough to justify the claim that the full ILS 642 million is effectively sitting inside the company waiting only to be spent. That is the important distinction.
The serious counter-thesis is that the company is conservative enough to do even that. It has net LTV of 35.6%, equity-to-assets of 51%, net financial debt to adjusted NOI of only 9.8, about ILS 1.43 billion of unencumbered real estate, and a stable rating. That is a good argument. But it holds only if investment pacing remains disciplined, if enhancement starts coming back through NOI rather than only through valuations, and if the breathing room created in 2025 and January 2026 is not immediately absorbed by fresh acquisitions or by an overly aggressive acceleration of the pipeline.
In plainer terms, Delek Israel Properties' balance sheet can finance the bridge, not the whole highway. If 2026 starts turning construction into NOI, that should be enough. If investment runs ahead of NOI and ahead of project debt, the pressure returns even without a covenant drama.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.